In this disucssion today we will go over the paper by Dr. David E Schine illustrating the possible role of Ivermectin to manage COVID hypercoagulable state.
Note: keep in mind that these are evolving sciences during the pandemic and the future studies may show the mechanisms to be incorrect or different.
We will review the following topics:
1. CD147 as a target for SARS-COV-2.
2. CD147 on RBCs
3. RBCs clumping during malaria because of CD147
4. A study conducted in Florida on 280 persons given Ivermectin and the outcome.
5. A Heparain study and CD147
6. Meplazumab's role
7. Recommended dose (theoratical.)
Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.